Brimonidine Nitroso Impurity 2
Specifications
Product name
Brimonidine Nitroso Impurity 2
SRC CAT No
SRC-N014466
CAS No
NA
Mol.F.
C11H9BrN6O
Mol.Wt.
321.13 g/mol
Related CAS No.
NA
Inv Status
CUSTOM SYNTHESIS
Chemical Structure
Product Overview
Description
Chemical Name
N-(5-Bromoquinoxalin-6-yl)-N-(4,5-dihydro-1H-imidazol-2-yl)nitrous amide
HSN Code
38229010
Synonym
N.A
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Brimonidine is used to relieve redness in the eyes caused by minor eye irritations (such as smog, swimming, dust, or smoke).Brimonidine Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Brimonidine Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Bromoquinoxalin-6-yl)-N-(4,5-dihydro-1H-imidazol-2-yl)nitrous amide . Synchemia is the leading manufacturing and exporter of Brimonidine Nitroso Impurity 2 . We supply Brimonidine Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Share your requirement and our team will take it forward with
clarity, confidentiality, and technical precision.
Related Products
N-Nitroso Dapsone 4-Hydroxyamino Impurity
| CAT No | SRC-N0142756 |
| CAS No | NA |
| Mol.F. | C12H10N2O5S |
| Mol.Wt. | 294.28 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Darifenacin Pyrrolidin Carboxylic Acid Impurity
| CAT No | SRC-N0142757 |
| CAS No | NA |
| Mol.F. | C18H18N2O3 |
| Mol.Wt. | 310.35 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Darifenacin Pyrrolidine Impurity Racemate
| CAT No | SRC-N0142758 |
| CAS No | NA |
| Mol.F. | C18H19N3O2 |
| Mol.Wt. | 309.37 g/mol |
| INV STATUS | In Stock |
N-Nitroso Darifenacin Dimer-1 Impurity
| CAT No | SRC-N0142759 |
| CAS No | NA |
| Mol.F. | C38H39N3O4 |
| Mol.Wt. | 601.75 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Darifenacin DBE Isomer
| CAT No | SRC-N0142760 |
| CAS No | NA |
| Mol.F. | C28H29N3O3 |
| Mol.Wt. | 455.56 g/mol |
| INV STATUS | In Stock |
N-Nitroso Darifenacin Impurity E
| CAT No | SRC-N0142761 |
| CAS No | NA |
| Mol.F. | C38H39N3O4 |
| Mol.Wt. | 601.75 g/mol |
| INV STATUS | In Stock |
N-Nitroso Darifenacin Impurity H
| CAT No | SRC-N0142762 |
| CAS No | NA |
| Mol.F. | C47H49N5O4 |
| Mol.Wt. | 747.94 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
Diclofenac Nitroso Impurity 1
| CAT No | SRC-N0142763 |
| CAS No | 68962-15-2 |
| Mol.F. | C12H9ClN2O |
| Mol.Wt. | g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Diclofenac Carboxylic Acid
| CAT No | SRC-N0142764 |
| CAS No | NA |
| Mol.F. | C13H8Cl2N2O3 |
| Mol.Wt. | 311.12 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Diclofenac Diethylamine
| CAT No | SRC-N0142765 |
| CAS No | NA |
| Mol.F. | C14H10Cl2N2O3 |
| Mol.Wt. | 325.15 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Diclofenac EP Impurity E
| CAT No | SRC-N0142766 |
| CAS No | NA |
| Mol.F. | C8H6N2O2 |
| Mol.Wt. | 162.15 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Diclofenac EP Impurity F
| CAT No | SRC-N0142767 |
| CAS No | NA |
| Mol.F. | C14H9Cl3N2O2 |
| Mol.Wt. | 343.59 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Diclofenac Glyceryl Impurity
| CAT No | SRC-N0142768 |
| CAS No | NA |
| Mol.F. | C17H16Cl2N2O5 |
| Mol.Wt. | 399.22 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Diclofenac Isopropyl Ester
| CAT No | SRC-N0142769 |
| CAS No | NA |
| Mol.F. | C17H16Cl2N2O3 |
| Mol.Wt. | 367.23 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Diclofenac Keto Analog
| CAT No | SRC-N0142770 |
| CAS No | NA |
| Mol.F. | C14H8Cl2N2O4 |
| Mol.Wt. | 339.13 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Diclofenac 4-Bromo Analog
| CAT No | SRC-N0142771 |
| CAS No | NA |
| Mol.F. | C14H10BrClN203 |
| Mol.Wt. | 369.60 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |